[1]
A. El-Heneidy, K. Grimwood, M. Rajmokan, A. Shrestha, S. Lambert, and R. Ware, “Nirsevimab provides age-specific protection against RSV hospitalisation in the first year of life: a population-level study in Queensland, Australia”, Commun Dis Intell (2018), vol. 50, Oct. 2026.